Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00403702

Comparison High-density Silicone Oils in Retinal Detachment

Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal Detachment

Status
Withdrawn
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Asociación para Evitar la Ceguera en México · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments.

Detailed description

Five to 10% of retinal detachments progressed to proliferative vitreoretinopathy (PVR), the common more cause of surgical failure of retina detachment. Despite the use of internal tamponades, the treatment of retinal detachments due to a progressed proliferative vitreoretinopathy (PVR) is still a problem. At present, conventional silicone oil, having a lower specific gravity than water, is an excellent tool in advanced PVR retinal detachment especially of the upper circumference. In the past, to diminish the re-detachments diverse heavier-than-water density endotamponades were investigated by to use in in cases of inferior PVR. However,heavier-than-water density endotamponades have demonstrated adverse short term effects. (Example: silicon dispersion: hypotension and inflammation) Recently, two new long-term heavier-than-water internal tamponades were introduced: Oxane HD \[oil-RMN3-mixture\] and Densiron \[mixture of 30.5 vol% perfluorohexyloctane (F6H8) with 69.5 vol% polydimethylsiloxane (silicone oil)\], showing satisfying anatomical results and good intraocular tolerance. In the present study, we will compare the anatomical outcome, functional results and intraocular adverse effects of two types of heavier tamponades.

Conditions

Interventions

TypeNameDescription
DRUGOxane HD [oil-RMN3-mixture]
DRUGDensiron [(F6H8)

Timeline

Start date
2006-08-01
Primary completion
2006-08-01
Completion
2007-08-01
First posted
2006-11-27
Last updated
2024-06-03

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT00403702. Inclusion in this directory is not an endorsement.